Skip to content
Clinical Trials – home
Therapeutic area

Cardiac disorders – page 37

  • 480 clinical trials
  • 223 recruiting
  • 172 conditions
  • 28 countries

Conditions in this area

172 conditions with trials, the busiest first

Clinical trials in Cardiac disorders

480 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

480 clinical trials

Pneumonia+2

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Amsterdam UMC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Gentofte Hospital
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Ivascular S.L.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sacubitril
  • Sponsor:Ziekenhuis Oost Limburg
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cipaglucosidase Alfa
  • Sponsor:Amicus Therapeutics Inc.
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 765845
  • Sponsor:Boehringer Ingelheim Espana S.A.
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
  • Sponsor:OMEICOS Therapeutics GmbH
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Zalunfiban
  • Sponsor:Celecor Therapeutics Inc.

Cardiac failure chronic+1

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trimetazidine Dihydrochloride
  • Sponsor:Medical University Of Gdansk

Cardiac failure+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Igg Against Serum Albumin Fused With Relaxin 2, Chain B (2-29) And Relaxin 2 (Chain A)
  • Sponsor:Eli Lilly & Co.

Substances studied in this area

The therapies tested most often in Cardiac disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.